{"title":"Plaatsbepaling adjuvant olaparib bij niet-gemetastaseerd HER2-negatief mammacarcinoom bij BRCA-kiembaanmutatie","authors":"afvaardiging Nederlandse Borstkankeroncologen","doi":"10.24078/onco.1970.1.23229","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":221680,"journal":{"name":"Medische Oncologie","volume":"5 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medische Oncologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24078/onco.1970.1.23229","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}